Diagnosis of the disease involves a combination of clinical performance, imaging, laboratory testing and pathological activation. The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of inherited purebred cell regeneration disorder Diamond-Blackfan requires individualized treatment regimens, typically including pharmacotherapy, rehabilitation interventions, periodic follow-up, and multi-dimensional management.
In recent years, significant improvements have been made in many previously difficult-to-treat blood tumour diseases with the development of therapeutic-focused, immune-regulating therapies and precision medicine. Therapeutic efficacy and adverse reactions need to be closely monitored throughout the treatment process, and regimens adjusted in a timely manner according to changes in the condition. Multidisciplinary collaboration MDT is particularly important for the integrated management of inherited purebred cell regeneration disorder Diamond-Blackfan.
The platform serves the China International Medical Service System, which combines a team of authoritative experts at home and abroad in the field of blood oncology, to provide the following services to patients: 1. Remote pre-diagnosis: pre-examination of medical history, precise diagnostic directions and medical advice by a team of experts; 2. Interviews in China: arranging face-to-face diagnosis with authoritative experts, developing personalized treatment programs; 3.
Full-service: providing one-stop services: providing medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects. Support for remote pre-diagnosis, visiting interviews, full translation and escort.